
BioNTech commits over $1B in COVID vaccine royalty settlements
Published on December 27, 2024
alliance extension, and $52 million toward a jointly managed R&D investment fund. The settlement resolves a lawsuit filed by UPenn in the US

alliance extension, and $52 million toward a jointly managed R&D investment fund. The settlement resolves a lawsuit filed by UPenn in the US